The Board shall advise the Director of CCR, and the Director and Deputy Director, NCI, on a wide variety of matters concerning scientific program policy and progress and future direction of research programs in the areas of basic sciences including experimental immunology, immunobiology, tumor immunology and biology, biochemistry, molecular immunoregulation, cellular oncology, cell biology, genetics, molecular biology, tumor cell biology, tumor virus biology, experimental pathology, molecular oncology, molecular virology, cellular and molecular biology, human carcinogenesis, viral carcinogenesis, biology, chemoprevention, carcinogenesis and tumor promotion, experimental carcinogenesis, basic carcinogenesis, biological chemistry, experimental immunology, biochemical physiology, medicinal chemistry, nutritional and molecular regulation, immune cell biology, leukocyte biology, molecular pharmacology, and mathematical biology.